New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest actionable point.

新型预防导向模型融合基因组学、人工智能驱动的风险评估、个性化监测以及由肿瘤学家主导的临床审查，旨在在癌症最早可干预阶段实现识别。

WEST PALM BEACH, Fla.

佛罗里达州西棕榈滩

,

，

July 1, 2026

2026年7月1日

/PRNewswire/ --

/美通社/ --

PreOncology

PreOncology

today announced the launch of the nation's first medical-grade, oncologist-led cancer prevention and early detection program, introducing an emerging subspecialty of medical oncology designed to move cancer care upstream, before cancer becomes advanced disease.

今日宣布启动全国首个由肿瘤科医生主导的医疗级癌症预防与早期检测项目，引入一个新兴的肿瘤内科亚专业，旨在将癌症护理提前至癌症发展为晚期疾病之前。

Rather than waiting until cancer is diagnosed, the

与其等到癌症被确诊，

PreOncology Program™

PreOncology 计划™

applies oncology expertise to risk assessment, surveillance planning, and evaluation of early biological signals, helping primary care physicians personalize cancer prevention based on each patient's individual biology.

将肿瘤学专业知识应用于风险评估、监测规划以及早期生物信号的评估，帮助初级保健医生根据每位患者的个体生物学特征制定个性化的癌症预防方案。

'Most cancer deaths occur after cancer has already spread,' said

“大多数癌症死亡发生在癌症已经扩散之后，”

Jose Barreau, MD

何塞·巴罗，医学博士

, Co-Founder of PreOncology and host of

，PreOncology 联合创始人兼主持人

The Chase: Inside the Race to Cure Cancer

《追逐：抗癌竞赛内幕》

. 'The greatest opportunity in oncology is not developing better treatments for metastatic disease. It is finding cancer before metastasis ever develops.'

“肿瘤学领域最大的机遇并非开发针对转移性疾病的更优疗法，而是在转移发生之前发现癌症。”

'If a cardiologist waited until a patient suffered a massive heart attack before becoming involved, we would consider that a failure of the healthcare system. Yet in oncology, we typically don't meet patients until after cancer has already formed.'

“如果心脏病专家等到患者发生严重心脏病发作后才介入，我们会认为这是医疗体系的失败。然而，在肿瘤学中，我们通常在癌症已经形成后才接触患者。”

Despite extraordinary advances in cancer therapy, today's screening system remains largely based on population averages—primarily age and broad risk categories. Many cancers still have no routine screening pathway, and for many patients the first indication of disease is a symptom that appears after the cancer has already progressed..

尽管癌症治疗取得了非凡进展，但目前的筛查体系仍然主要基于人群平均水平——主要是年龄和广泛的风险类别。许多癌症仍然没有常规的筛查途径，对于许多患者来说，疾病的首个迹象往往是癌症已经进展后出现的症状。

PreOncology was created to address that gap by replacing one-size-fits-all screening with continuous, individualized cancer prevention and early detection.

PreOncology 的创立旨在填补这一空白，以持续、个性化的癌症预防和早期检测取代“一刀切”式的筛查。

At the center of the program is the

该计划的核心是

Stage Alpha Operating System™

Stage Alpha 操作系统™

(patent pending), a clinical intelligence platform designed to monitor

（专利申请中），一个旨在监测的临床智能平台

Oncologic Biological Drift

肿瘤生物学漂移

—the way an individual's cancer risk, biology, and clinical signals evolve over time—and identify the earliest point at which meaningful intervention becomes possible.

——个体癌症风险、生物学特征及临床信号随时间的演变方式——并确定有意义干预成为可能的最早时间点。

The platform combines three core capabilities:

该平台融合了三大核心能力：

Dynamic Risk Engine

动态风险引擎

— Individualized cancer risk assessment powered by whole genome sequencing, clinical history, family history, lifestyle factors, biomarkers, and machine learning.

— 基于全基因组测序、临床病史、家族史、生活方式因素、生物标志物和机器学习的个性化癌症风险评估。

Protocol Optimization

协议优化

— Personalized surveillance strategies using detection mathematics to determine which screening technologies should be used, when they should be performed, and how often they should be repeated.

— 利用检测数学制定个性化监测策略，以确定应使用哪些筛查技术、何时进行以及重复频率。

Signal Review

信号审查

— Oncologist-led review of abnormal findings and emerging biological signals through a dedicated Signal Board that helps physicians determine appropriate next steps.

— 由肿瘤科医生主导，通过专门的信号评估委员会对异常发现和新兴生物学信号进行审查，帮助医生确定适当的后续步骤。

'Cancer risk is dynamic, not static,' said

“癌症风险是动态的，而非静态的。”

Russell Rockne, PhD

拉塞尔·罗克尼，博士

, Director of Mathematical Oncology at City of Hope and Scientific Advisor to PreOncology. 'As we better understand tumor biology, individual risk, and the performance of detection technologies, there is an opportunity to move beyond one-size-fits-all screening toward surveillance strategies that are mathematically tailored for each person.'.

，希望之城数学肿瘤学主任兼PreOncology科学顾问。“随着我们对肿瘤生物学、个体风险以及检测技术性能的理解不断深入，我们有机会超越‘一刀切’的筛查模式，转向为每个人量身定制的数学化监测策略。”

'Cancer prevention is not about ordering more tests,' said

“癌症预防并不是意味着要做更多的检查，”

Amit Gupta, MD

阿米特·古普塔，医学博士

, Co-Founder and Chief Scientific Officer of PreOncology. 'It is about knowing which tests make sense, for which patients, when to use them, and what to do with the information. A blood test, scan, or genetic result is a tool—not an answer. The value comes from the clinical program built around it.'.

PreOncology 联合创始人兼首席科学官表示：“关键在于了解哪些检测具有临床意义、适用于哪些患者、何时使用以及如何解读相关信息。血液检测、影像学扫描或基因检测结果只是工具，而非最终答案。其价值源于围绕这些工具构建的临床诊疗方案。”

The PreOncology Dynamic Risk Engine is built using approximately

PreOncology 动态风险引擎采用约

3.1 million de-identified patient records

310万份去标识化患者记录

derived from many of the same large prospective research studies that underpin national cancer screening guidelines. For lung cancer alone, the model incorporates data from more than

源自许多支撑国家癌症筛查指南的大型前瞻性研究。仅就肺癌而言，该模型整合了来自超过

611,000 individuals

61.1万人

, substantially expanding the evidence base available for individualized risk assessment.

，大幅扩充了可用于个体化风险评估的证据基础。

Unlike direct-to-consumer screening products or single-technology approaches, the PreOncology Program is technology agnostic. Screening technologies are evaluated continuously using a structured clinical framework that considers sensitivity, specificity, evidence quality, patient burden, and overall clinical utility before being incorporated into a personalized surveillance strategy..

与直接面向消费者的筛查产品或单一技术方法不同，PreOncology 计划不依赖于特定技术。该计划采用结构化的临床框架，对筛查技术进行持续评估，在将其纳入个性化监测策略之前，综合考量其敏感性、特异性、证据质量、患者负担以及整体临床效用。

The program is delivered through concierge and direct primary care physicians, allowing patients to remain under the care of their trusted physician while adding the expertise of board-certified medical oncologists focused on prevention and ultra-early detection.

该项目通过礼宾式医疗服务和直接初级保健医师提供，使患者在继续接受其信任的医师照护的同时，还能获得专注于预防及超早期检测的董事会认证肿瘤内科专家的专业支持。

The PreOncology Program is available through participating concierge and direct primary care practices in Florida, with national expansion planned.

PreOncology项目可通过佛罗里达州参与的私人医生服务和直接初级保健诊所获得，并计划在全国范围内扩展。

Looking ahead, PreOncology plans to continue advancing the Stage Alpha Operating System, expand its AI-driven clinical intelligence platform, pursue regulatory pathways for software-based clinical decision support, and partner with health systems, employers, and payers to make personalized cancer prevention more broadly available..

展望未来，PreOncology计划继续推进Alpha阶段操作系统，扩展其人工智能驱动的临床智能平台，探索基于软件的临床决策支持的监管路径，并与医疗系统、雇主和支付方合作，使个性化癌症预防更广泛地普及。

About PreOncology

关于 PreOncology

PreOncology™ is an emerging subspecialty of medical oncology focused on preventing cancer and finding it earlier—before it becomes advanced disease. Founded by board-certified medical oncologists Jose Barreau, MD, and Amit Gupta, MD, the PreOncology Program™ integrates whole genome sequencing, clinical data, biomarkers, imaging, artificial intelligence, and longitudinal risk modeling to generate individualized cancer risk assessments, personalized surveillance strategies, and expert review of early biological signals..

PreOncology™ 是肿瘤内科中一个新兴的亚专科，专注于癌症预防及在癌症发展为晚期疾病之前尽早发现。该学科由获得董事会认证的肿瘤内科医生 Jose Barreau 医学博士和 Amit Gupta 医学博士创立，其 PreOncology Program™ 整合全基因组测序、临床数据、生物标志物、影像学、人工智能以及纵向风险建模，以生成个体化的癌症风险评估、个性化监测策略，并对早期生物学信号进行专家审阅。

Through its Stage Alpha Operating System™ (patent pending), PreOncology brings oncology expertise upstream, working alongside primary care physicians with the goal of detecting cancer at the earliest actionable point, when cure is most achievable.

通过其Stage Alpha操作系统™（专利申请中），PreOncology将肿瘤学专业能力前移，与初级保健医生协同合作，旨在在最具可操作性的最早阶段检测癌症，此时治愈的可能性最高。

For more information, visit

更多信息，请访问

www.preoncology.com

www.preoncology.com

.

。

Media Contact

媒体联系人

Jenny Greenland-Zee

珍妮·格林兰-齐

[email protected]

[email protected]

SOURCE PreOncology

来源 PreOncology

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示